Pier P. Pandolfi

Affiliations: 
Weill Cornell Medical College, New York, NY, United States 
Area:
Cell Biology, Genetics, Molecular Biology, Oncology
Google:
"Pier Pandolfi"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu XS, Chandramouly G, Rass E, et al. (2015) LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. Nature Communications. 6: 8325
Lunardi A, Varmeh S, Chen M, et al. (2015) Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis. Cancer Discovery. 5: 550-63
Guarnerio J, Riccardi L, Taulli R, et al. (2015) A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells. Cancer Discovery. 5: 396-409
Morotti A, Panuzzo C, Crivellaro S, et al. (2014) BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP. Leukemia. 28: 1326-33
Berger AH, Chen M, Morotti A, et al. (2013) DOK2 inhibits EGFR-mutated lung adenocarcinoma. Plos One. 8: e79526
Wang G, Lunardi A, Zhang J, et al. (2013) Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nature Genetics. 45: 739-46
Lunardi A, Ala U, Epping MT, et al. (2013) A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics. 45: 747-55
Lunardi A, Guarnerio J, Wang G, et al. (2013) Role of LRF/Pokemon in lineage fate decisions. Blood. 121: 2845-53
Berger AH, Knudson AG, Pandolfi PP. (2012) Dosage and tumour suppression. The Journal of Pathology. 227: e1; author reply e2
Berger AH, Knudson AG, Pandolfi PP. (2011) A continuum model for tumour suppression. Nature. 476: 163-9
See more...